Evidence map›Paper›PMID 37052911›Full record

ArticleTranslational vision science & technology2023

Characterization of the Molecular Weight of Hyaluronan in Eye Products Using a Novel Method of Size Exclusion High-Pressure Liquid Chromatography.

Lawrence Nguyen, Xiao Lin, Sudhir Verma, Sudan Puri, Vincent Hascall, Tarsis Ferreira Gesteira, Vivien J Coulson-Thomas

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Engineered Tandem Thymosin Peptide Promotes Corneal Wound Healing.Investigative ophthalmology & visual science · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Age related changes in hyaluronan expression leads to Meibomian gland dysfunction.Matrix biology : journal of the International Society for Matrix Biology · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Lawrence NguyenCollege of Optometry, University of Houston, Houston, TX, USA.
Xiao LinCollege of Optometry, University of Houston, Houston, TX, USA.
Sudhir VermaCollege of Optometry, University of Houston, Houston, TX, USA.
Sudan PuriCollege of Optometry, University of Houston, Houston, TX, USA.
Vincent HascallCleveland Clinic, Cleveland, OH, USA.
Tarsis Ferreira GesteiraCollege of Optometry, University of Houston, Houston, TX, USA.
Vivien J Coulson-ThomasCollege of Optometry, University of Houston, Houston, TX, USA.
University of Houston · USCleveland Clinic · USUniversity of Delhi · IN

Funding

Research Programming ModuleP30EY007551 · NEI · UNIVERSITY OF HOUSTON · PI LAURA J. FRISHMAN · 1988 to 2026
$16.4M
Hyaluronan in the limbal stem cell niche: from regulation of stem cell fate to translational applicationsR01EY029289 · NEI · UNIVERSITY OF HOUSTON · PI Vivien Jane Coulson-Thomas · 2018 to 2026
$3.0M
Modifying the extracellular matrix to prevent dry eye disease and age-related Meibomian gland dysfunction (ARMGD)R01EY033024 · NEI · UNIVERSITY OF HOUSTON · PI COULSON-THOMAS, VIVIEN JANE · 2022 to 2025
$1.6M
NEI NIH HHS P30 EY007551NEI NIH HHS R01 EY029289NEI NIH HHS R01 EY033024
6 · The paper itself

Abstract

Purpose: Hyaluronan (HA) exists in two forms, high molecular weight HA (HMWHA) and low molecular weight HA (LMWHA), which have distinct physiological functions. Therefore it is imperative to know the form of HA within pharmaceutical products, including eye products. This study developed an accurate, sensitive, and quantitative method to characterize the form of HA in eye products. Thereafter, the effects of the HA-containing eye products on corneal wound healing were investigated. Methods: The MW distributions and concentrations of HA in over the counter eye products were determined by size exclusion chromatography (SEC) high-pressure liquid chromatography (HPLC). The effects of the eye products containing HA on corneal wound healing were characterized both in vitro and in vivo using the scratch assay and the debridement wound model, respectively. Results: The concentrations and MWs of HA were successfully determined within a range of 0.014 to 0.25 mg/mL using SEC HPLC. The concentrations of HA in the ophthalmic products varied from 0.14 to 4.0 mg/mL and the MWs varied from ∼100 kDa to >2500 kDa. All but one HA-containing eye product had an inhibitory effect on corneal wound healing, whereas pure HA promoted corneal wound healing. Conclusions: A novel SEC-HPLC method was developed for quantifying and characterizing the MW of HA in eye products. Although HA promoted corneal wound healing, HA-containing eye products inhibited corneal wound healing, likely caused by preservatives. Translational Relevance: SEC-HPLC could be implemented as a routine method for determining the form of HA in commercially available ophthalmic products.

Indexed as

Corneal InjuriesHyaluronic AcidChromatography, High Pressure LiquidCorneaHumansMolecular WeightWound HealingHyaluronic Acid

Identifiers

PMID37052911
PMCPMC10103721
OpenAlexW4365443890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.